Journal of Dermatological Treatment

Article	Citations
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis	111
A systematic review of recent randomized controlled trials for palmoplantar pustulosis	65
Skin type classifications: does the perfect assessment exist?	65
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist	50
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy	47
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most	44
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab	44
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial	38
Lessons from a decentralized trial in atopic dermatitis: promises and perils	37
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants	36
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	34
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)	33
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso	29
Topical delgocitinib for the treatment of chronic hand eczema	28
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa	26
Finally, successful interventions to ameliorate cutaneous infestations	25
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry	23
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)	23
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients	23
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	22
A pediatric case of dupilumab-induced pustular psoriasis	22
Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report	21
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	21
Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib	21
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses	20

Driving taxis	20
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years	18
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study	18
Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review	18
Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study	18
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study	18
The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study	18
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study	17
Racial disparities in the management of skin ulcers: an analysis of the National Ambulatory Medical Care Survey, 2012–2018	17
The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy	17
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	17
Unmet needs in atopic dermatitis management: an expert consensus	17
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study –	17
A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency	16
Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis	16
The changes of leukocytes and T lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in control group in pollen season compared to out of pollen season	16
Correction	16
Preoperative and postoperative evaluation of survivin in peripheral blood of patients with non-melanoma skin cancers. A pilot study	16
Topical treatment for postinflammatory hyperpigmentation: a systematic review	15
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	15
Exploring the potential of nanocarriers in antipsoriatic therapeutics	15
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib	14
Psychosocial interventions for psoriasis: a Bayesian network meta-analysis	14
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis	14
Baricitinib for the treatment of atopic dermatitis	14
Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa	14
Utilizing artificial intelligence technology with emotional intelligence in clinical office visits	13
Pre-operative ultrasound localization of misdiagnosed foreign object as verruca vulgaris: a case report	13
Successful treatment of SAPHO syndrome with oral abrocitinib: a case report	13
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report	13
From clinical trial to real world evidence: a learning healthcare environment	13
Correction	13
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study	13
Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network	12
Uses of eye drops in dermatology, literature review	12
Axonal sensorimotor polyneuropathy after starting guselkumab	12
A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations	12
BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome	12
Years of dermatology experience and geographic region are associated with outlier performance of excision or destruction for nonmelanoma skin cancer	12
Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus	12
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD	12
A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity	12
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	12
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study	12
Managing dry skin in patients with comorbidities or with advanced age: unmet needs and roles for products containing potential emollient-plus ingredients	12
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence	11
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin	11
Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide?	11
Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?	11
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study	11

The development and initial evaluation of conversation cards for optimizing consultations for patients with atopic dermatitis	11
Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan	11
Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab	11
Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study	11
Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network meta-analysis	11
Vitiligo outpatient management in the United States: findings from the 2012–2019 National Ambulatory Medical care Survey (NAMCS)	11
A new method to treat onychopapilloma with pulsed dye laser irradiation: a 13-case series report	11
Polynucleotide-based treatments for various facial scars including combat injuries	11
Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis	10
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis	10
Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis	10
Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special	10
Phototherapy trends in dermatology 2015–2018	10
Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders	10
Treatment of eosinophilic annular erythema with upadacitinib	10
Botanical extract combined with minoxidil improve hidrotic ectodermal dysplasia caused by p.G11R mutations: a case report	10
Doxycycline monotherapy for pyoderma vegetans: a case report	10
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience	9
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	9
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy	9
Successful treatment of cutaneous polyarteritis nodosa with baricitinib	9
The efficacy of combined phototherapy with topical therapy in vitiligo: a network meta-analysis	9
Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab	9
New insights into delusional infestation	9
Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis	9
Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy	9
Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report	9
Biodegradable polymers and platelet-rich plasma causing visual impairment: a literature review	9
Emerging treatments for bullous pemphigoid	9
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study	9
Whether the transient hair shedding phase exist after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients	9
Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis	9
An innovative approach in the treatment of trigeminal trophic syndrome	8
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial	8
A case of generalized eosinophilic pustular folliculitis: treatment with JAK inhibitor	8
Delusional infestation: a case for preserving pimozide as an option	8
Silicone-induced granulomas successfully treated with adalimumab	8
Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review	8
Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin	8
Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo	8
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years	8
RETRACTED ARTICLE: Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report	8
Psoriasis treatment patterns and outcomes with ixekizumab in a real-world setting: results from a single US dermatology referral practice	8
Complementary and alternative treatment methods practiced by parents in pediatric cases diagnosed with atopic dermatitis	8
Another transition	8
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional,	8
Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases	8
Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment	8
Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma	7
Human adipose tissue-derived MSCs improve psoriasis-like skin inflammation in mice by negatively regulating ROS	7
Treatment of nail diseases in the emergency department	7
Letter to the editor submitted in response to “Minoxidil: a comprehensive review”	7
Effects and safety of fire needle adjuvant chemical peels therapy in acne vulgaris: a systematic review and meta-analysis	7
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland	7
A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab	7
Hyperhidrosis and the risk of being treated for skin infections	7
Efficacy and safety of stromal vascular fraction on scar revision surgery: a prospective study	7
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international pat	7
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	7
The effects of topical antimicrobial-corticosteroid combination therapy in comparison to topical steroids alone on the skin microbiome of patients with atopic dermatitis	7
Dermatology in a changing world	7
Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis	7
Experiences and coping behaviors of patients with psoriasis: a qualitative study	7
Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases	7
Clinical observations on super relaxation suture in the resection of benign skin tumor in children	7
Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review	7
Baseline hair loss severity as a potential confounder in studies on minoxidil and low-level laser therapy	7
Assessing secondary adherence to topical treatments: scoping review revealing lack of standardized approach in clinical research	7
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries	7
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective	6
A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study	6
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up st	6
Development and validation of a prognostic nomogram model in primary cutaneous and subcutaneous soft tissue angiosarcoma	6
Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study	6
The impact of hormones in autoimmune cutaneous diseases	6
Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient's perspective	6
Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa	6
Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials	6
Itraconazole versus propranolol: therapeutic and pharmacologic effect on serum angiopoietin-2 in patients with infantile hemangioma	6
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis	6

Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne	6
Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting	6
Two cases of lupus miliaris disseminatus faciei successfully treated with oral tofacitinib	6
Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life	6
Efficacy and safety of a novel 785 nm picosecond neodymium-doped yttrium aluminum garnet laser for the treatment of facial benign pigmented lesions in Asian skin: a pilot study	6
Analysis of utilization, cost and prescription trends of mycophenolate mofetil and methotrexate among medicare patients	6
Pityriasis alba: toward an effective treatment	6
Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient	6
Preliminary analysis of the efficacy of Mohs micrographic surgery combined with photodynamic therapy in a case of noninvasive extramammary Paget’s disease	6
Anatomical-based diagnosis and filler injection techniques: marionette line (static labiomandibular fold)	6
Comparison of the onset, depth, and duration of cutaneous anesthesia between topical 10% lidocaine and EMLA creams: a randomized, intraindividual, comparative trial	6
Patient preferences for atopic dermatitis treatments: a discrete choice experiment	6
Development of a new classification and scoring system for scalp conditions: Scalp Photographic Index (SPI)	5
Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review	5
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors	5
A new hope in the treatment of onychogryphosis due to acquired malalignment of great toenails: intramatrix dexpanthenol injection	5
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness	5
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis – a pilot study	5
Killing all the birds with one drug – is oral roflumilast a novel treatment option for psoriasis?	5
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals	5
Hedgehog pathway inhibitors (HHI) combined with radiotherapy and immunotherapy for advanced basal cell carcinoma: a case report	5
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia	5
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials	5
Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps	5
The relative weak way and the absolute strong way to communicate risk information	5
Social media voices on the treatment of skin psoriasis with biologics	5
Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients	5
Pattern hair loss distribution: a novel presentation for alopecia areata	5
A case of topical imiquimod induced fatigue	5
Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study	5
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment	5
The impact of social media on dermatologists and in captivating their patients: a cross-sectional study	5
Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab	5
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry	5
Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004–2023)	5
Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad	5
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface dis	5
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks	5
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials	5
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa	5
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma	5
UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities	5
Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis	5
Health disparities in psoriasis: geographic barriers to access in the United States	5
Association of pruritus and chronic cough: an all of us database study	5
Monitoring adherence to vulvar lichen sclerosus treatment – a prospective study	5
The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis	5
Are cyclosporine eye drops a suitable treatment in ocular rosacea?	5
Behcet’s-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review	4
Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience	4
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group	4
Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study	4
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study	4
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials	4
The landscape of vitiligo in Latin America: a call to action	4
Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials	4
The evolving landscape for vitiligo management	4
Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in Australia	4
A systematic review investigating the proportion of clinical images shared in prospective randomized controlled trials involving patients with atopic dermatitis and systemic pharmacotherapy	4
Modalities of treatment for Nevus depigmentosus: review of the literature	4
Mandated step therapy for dupilumab delays the inevitable	4
An updated systematic review and meta-analysis of efficacy and safety of Chinese herbal medicine for treating atopic dermatitis	4
Ocular side effects of systemic isotretinoin – a systematic review and summary of case reports	4
Pemphigus foliaceus treated with minocycline monotherapy or low-dose prednisolone combination therapy	4
Low-dose oral minoxidil in a case of short anagen syndrome	4
Patients with vulvar lichen sclerosus prioritize education on disease etiology, triggers and treatment	4
Patient preferences for topical psoriasis treatments: a discrete choice experiment	4
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study	4
Age-based treatment differences in and reluctance to treating older adults with systemic antipsoriatic therapy – a mixed-method pilot study	4
Unlocking potential: clinical benefits of enlarging the nail bed explored through continuous W-shaped incisions	4
Off-label dermatologic uses of IL-23 inhibitors	4
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials	4
The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa	4
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors	4
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy	4
Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States	4
Time to codify a challenge in communication	4
A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging	4
Self-perceived disease control in childhood eczema	4
Hemodynamic changes during conventional and daylight photodynamic therapy of actinic keratoses – a randomized controlled trial	4
Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study	4
Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting	4
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience	4
Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics	4
Efficacy analysis of blunt separation combined with uncrosslinked sodium hyaluronate compound solution injection for sunken upper eyelid treatment in Asians	4
TNF-α inhibitors as therapy for drug-induced severe cutaneous adverse reactions: a case series	4
Risk of fetal malformation, spontaneous abortion, and adverse pregnancy outcomes after gestational terbinafine exposure: a systematic review	4
A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis	4
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa	4
Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets	4
Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated	4
Introducing a simplified titration scheme for dimethylfumarate (DMF) in patients with moderate-to-severe psoriasis: a case series	4
A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs	4
Recommendations to optimize gender neutrality in iPLEDGE	3
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment	3